| Predicate |
Object |
| contentType |
Comment|Editorial |
| endingPage |
827 |
| issn |
0735-1097 |
| issueIdentifier |
8 |
| pageRange |
826-827 |
| publicationName |
Journal of the American College of Cardiology |
| startingPage |
826 |
| bibliographicCitation |
Francescone S, Halperin JL. \"Triple therapy\" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents. J Am Coll Cardiol. 2008 Feb 26;51(8):826–7. doi: 10.1016/j.jacc.2007.11.034. PMID: 18294567. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7432bc7bff17e4fba1499b9a8cb06af
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0532e66f4dfce80144a31105152d2500 |
| date |
2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/18294567
https://doi.org/10.1016/j.jacc.2007.11.034 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0735-1097
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4429 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
\"Triple therapy\" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents |
| discusses |
http://id.nlm.nih.gov/mesh/M0008434
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0022871
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0414250 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001281Q000150
http://id.nlm.nih.gov/mesh/D005343Q000627
http://id.nlm.nih.gov/mesh/D013923Q000209
http://id.nlm.nih.gov/mesh/D011725Q000627
http://id.nlm.nih.gov/mesh/D015607Q000009
http://id.nlm.nih.gov/mesh/D014859Q000627
http://id.nlm.nih.gov/mesh/D015906Q000009
http://id.nlm.nih.gov/mesh/D013923Q000517
http://id.nlm.nih.gov/mesh/D001241Q000627 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012307 |